JAK3 and breast cancer: Kim et al [61], [62] observed enhanced MMP-9 activity mediated through JAK3/ERK pathway in EGF treated SKBR3 breast cancer cells, whereas Park et al [63] showed enhanced MMP-1 activity through the involvement of ERK/MAPK signalling pathways.